株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

補助人工心臓(VAD)の世界市場:2020年~2024年

Ventricular Assist Devices Market by Product and Geography - Forecast and Analysis 2020-2024

発行 TechNavio (Infiniti Research Ltd.) 商品コード 239360
出版日 ページ情報 英文 145 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.19円で換算しております。
Back to Top
補助人工心臓(VAD)の世界市場:2020年~2024年 Ventricular Assist Devices Market by Product and Geography - Forecast and Analysis 2020-2024
出版日: 2019年11月29日 ページ情報: 英文 145 Pages
概要

世界の補助人工心臓(VAD)市場は、2020年から2024年にかけておよそ12%のCAGRで成長すると予測されています。心不全の有病率の増加や、技術の進歩、移植ドナーの不足などが当市場の成長を促進する要因となっています。

当レポートでは、世界の補助人工心臓(VAD)市場を調査し、市場の概要、製品・地域別の市場規模の推移と予測、市場の成長要因および課題の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 レポート範囲

第3章 市場状況

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場の定義
  • 市場規模
  • 市場規模および予測

第5章 ファイブフォース分析

  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
  • 市況

第6章 市場セグメンテーション:製品別

  • 市場区分:製品別
  • 市場比較:製品別
  • 左心室補助人工心臓(LVAD)・右心補助人工心臓(RVAD)
  • 両心補助人工心臓(BVAD)
  • 市場機会:製品別

第7章 顧客情勢

第8章 地域情勢

  • 市場区分:地域別
  • 市場比較:地域別
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第9章 意思決定の枠組み

第10章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第11章 市場動向

  • 技術の進歩
  • 合併・買収
  • パイプラインの新製品

第12章 ベンダー情勢

  • 概要
  • 創造的破壊の状況
  • 競争シナリオ

第13章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • Abiomed Inc.
  • 旭化成
  • Berlin Heart GmbH
  • CorWave SA
  • Fresenius Medical Care AG & Co. KGaA
  • Jarvik Heart Inc.
  • LivaNova Plc
  • Medtronic Plc
  • Mohawk Innovative Technology Inc.

第14章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場ポジショニングの定義

第15章 Technavioについて

図表

LIST OF EXHIBITS:

  • Exhibit 01: Global healthcare equipment market
  • Exhibit 02: Segments of global healthcare equipment market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Vendors: Product overview
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Product - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Left and right ventricular assist devices - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Left and right ventricular assist devices - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Bi-ventricular assist devices - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Bi-ventricular assist devices - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2019-2024 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Product launch details and market impact analysis
  • Exhibit 39: Product recalls
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Business strategies and their market impact analysis
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: Abbott Laboratories - Vendor overview
  • Exhibit 48: Abbott Laboratories - Business segments
  • Exhibit 49: Abbott Laboratories - Organizational developments
  • Exhibit 50: Abbott Laboratories - Geographic focus
  • Exhibit 51: Abbott Laboratories - Segment focus
  • Exhibit 52: Abbott Laboratories - Key offerings
  • Exhibit 53: Abbott Laboratories - Key customers
  • Exhibit 54: Abiomed Inc. - Vendor overview
  • Exhibit 55: Abiomed Inc. - Business segments
  • Exhibit 56: Abiomed Inc. - Organizational developments
  • Exhibit 57: Abiomed Inc. - Geographic focus
  • Exhibit 58: Abiomed Inc. - Key offerings
  • Exhibit 59: Abiomed Inc. - Key customers
  • Exhibit 60: Asahi Kasei Corp. - Vendor overview
  • Exhibit 61: Asahi Kasei Corp. - Business segments
  • Exhibit 62: Asahi Kasei Corp. - Organizational developments
  • Exhibit 63: Asahi Kasei Corp. - Geographic focus
  • Exhibit 64: Asahi Kasei Corp. - Segment focus
  • Exhibit 65: Asahi Kasei Corp. - Key offerings
  • Exhibit 66: Asahi Kasei Corp. - Key customers
  • Exhibit 67: Berlin Heart GmbH - Vendor overview
  • Exhibit 68: Berlin Heart GmbH - Business segments
  • Exhibit 69: Berlin Heart GmbH - Key offerings
  • Exhibit 70: Berlin Heart GmbH - Key customers
  • Exhibit 71: CorWave SA - Vendor overview
  • Exhibit 72: CorWave SA - Business segments
  • Exhibit 73: CorWave SA - Organizational developments
  • Exhibit 74: CorWave SA - Key offerings
  • Exhibit 75: CorWave SA - Key customers
  • Exhibit 76: Fresenius Medical Care AG & Co. KGaA - Vendor overview
  • Exhibit 77: Fresenius Medical Care AG & Co. KGaA - Business segments
  • Exhibit 78: Fresenius Medical Care AG & Co. KGaA - Organizational developments
  • Exhibit 79: Fresenius Medical Care AG & Co. KGaA - Geographic focus
  • Exhibit 80: Fresenius Medical Care AG & Co. KGaA - Segment focus
  • Exhibit 81: Fresenius Medical Care AG & Co. KGaA - Key offerings
  • Exhibit 82: Fresenius Medical Care AG & Co. KGaA - Key customers
  • Exhibit 83: Jarvik Heart Inc. - Vendor overview
  • Exhibit 84: Jarvik Heart Inc. - Business segments
  • Exhibit 85: Jarvik Heart Inc. - Key offerings
  • Exhibit 86: Jarvik Heart Inc. - Key customers
  • Exhibit 87: LivaNova Plc - Vendor overview
  • Exhibit 88: LivaNova Plc - Business segments
  • Exhibit 89: LivaNova Plc - Organizational developments
  • Exhibit 90: LivaNova Plc - Geographic focus
  • Exhibit 91: LivaNova Plc - Segment focus
  • Exhibit 92: LivaNova Plc - Key offerings
  • Exhibit 93: LivaNova Plc - Key customers
  • Exhibit 94: Medtronic Plc - Vendor overview
  • Exhibit 95: Medtronic Plc - Business segments
  • Exhibit 96: Medtronic Plc - Organizational developments
  • Exhibit 97: Medtronic Plc - Geographic focus
  • Exhibit 98: Medtronic Plc - Segment focus
  • Exhibit 99: Medtronic Plc - Key offerings
  • Exhibit 100: Medtronic Plc - Key customers
  • Exhibit 101: Mohawk Innovative Technology Inc. - Vendor overview
  • Exhibit 102: Mohawk Innovative Technology Inc. - Product segments
  • Exhibit 103: Mohawk Innovative Technology Inc. - Key offerings
  • Exhibit 104: Mohawk Innovative Technology Inc. - Key customers
  • Exhibit 105: Validation techniques employed for market sizing
  • Exhibit 106: Definition of market positioning of vendors
目次
Product Code: IRTNTR40227

About this market

Technavio's ventricular assist devices market analysis considers sales from left and right ventricular assist devices and bi-ventricular assist devices products. Our study also finds the sales of ventricular assist devices in Asia, Europe, North America, and ROW. In 2019, the left and right ventricular assist devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increasing prevalence of end-stage heart failure and rising number of new product launches will play a significant role in the left and right ventricular assist devices segment to maintain its market position. Also, our global ventricular assist devices market report looks at factors such as increasing prevalence of heart failure, new product launches, and scarcity of donor hearts for transplantation. However, high costs associated with ventricular assist devices, complications related to implantation of ventricular assist devices, and frequent product recalls may hamper the growth of the ventricular assist devices industry over the forecast period.

Overview

Increasing prevalence of heart failure

Patients who suffer from chronic cardiovascular diseases have a high risk of developing heart failure. Ischemic heart disease is found to be one of the most common causes of heart failure. Surgeons use implantable mechanical pumps such as ventricular assist devices in patients with heart failure or those with a weak heart muscle. In addition, the implantation of ventricular assist devices is also recommended for patients with congestive heart failure. Thus, the increasing prevalence of heart failure will lead to the expansion of the global ventricular assist devices market at a CAGR of almost 12% during the forecast period.

Technological advances

The procurement and maintenance of medical equipment account for a significant part of a healthcare organization's operational expenses. However, growing technological innovations have enabled a paradigm shift in the cost as well as the manageability of medical equipment. Technologically advanced and innovative ventricular assist devices are used to aid in cardiac circulation, which can partially or completely replace the function of the heart. Second-generation ventricular assist devices include implantable, continuous flow, rotary pumps with axial flow. Market vendors are also developing third-generation ventricular support devices that are incorporated with centrifugal continuous-flow pumps, which provide enhanced durability and reliability. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global ventricular assist devices market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of several major players, the global ventricular assist devices market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ventricular assist devices manufacturers, that include Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Berlin Heart GmbH, CorWave SA, Fresenius Medical Care AG & Co. KGaA, Jarvik Heart Inc., LivaNova Plc, Medtronic Plc, and Mohawk Innovative Technology Inc.

Also, the ventricular assist devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Value chain analysis
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Left and right ventricular assist devices - Market size and forecast 2019-2024
  • Bi-ventricular assist devices - Market size and forecast 2019-2024
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Technological advances
  • Growing number of mergers and acquisitions
  • New products in the ventricular assist devices pipeline

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • Abiomed Inc.
  • Asahi Kasei Corp.
  • Berlin Heart GmbH
  • CorWave SA
  • Fresenius Medical Care AG & Co. KGaA
  • Jarvik Heart Inc.
  • LivaNova Plc
  • Medtronic Plc
  • Mohawk Innovative Technology Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

Back to Top